These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26699933)

  • 1. Allogeneic Hematopoietic Stem Cell Transplantions in Blastic Plasmacytoid Dendritic Cell Neoplasm in first complete remission: an effective therapy for a rare disease.
    Deotare U; Kim DD; Michelis FV; Lipton JH
    Leuk Lymphoma; 2016 Aug; 57(8):1942-4. PubMed ID: 26699933
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience.
    Heinicke T; Hütten H; Kalinski T; Franke I; Bonnekoh B; Fischer T
    Ann Hematol; 2015 Feb; 94(2):283-7. PubMed ID: 25138222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
    Sakashita K; Saito S; Yanagisawa R; Tanaka M; Yoshikawa K; Hirabayashi K; Tsukahara K; Motobayashi M; Nakazawa Y; Koike K
    Pediatr Blood Cancer; 2013 Nov; 60(11):E140-2. PubMed ID: 23788509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic.
    Cernan M; Szotkowski T; Hisemova M; Cetkovsky P; Sramkova L; Stary J; Racil Z; Mayer J; Sramek J; Jindra P; Visek B; Zak P; Novak J; Kozak T; Furst T; Papajik T
    Neoplasma; 2020 May; 67(3):650-659. PubMed ID: 32064883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?
    Leclerc M; Peffault de Latour R; Michallet M; Blaise D; Chevallier P; Rohrlich PS; Turlure P; Nguyen S; Jardin F; Yakoub-Agha I; Maury S;
    Blood; 2017 Mar; 129(9):1227-1230. PubMed ID: 27986653
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic Hematopoietic Cell Transplantation Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm in First Complete Remission: Systematic Review and Meta-analysis.
    Kharfan-Dabaja MA; Reljic T; Murthy HS; Ayala E; Kumar A
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):703-709.e1. PubMed ID: 30145196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm.
    Falcone U; Sibai H; Deotare U
    Crit Rev Oncol Hematol; 2016 Nov; 107():156-162. PubMed ID: 27823644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Very Rare Type of Leukemia in a Young Pediatric Patient Treated With Hematopoietic Stem Cell Transplantation: Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Tekkeşin F; Asarcikli F; Yildirim ÜM; Zemheri IE; Kiliç SÇ
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e288-e291. PubMed ID: 33235146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.
    Piccin A; Morello E; Svaldi M; Haferlach T; Facchetti F; Negri G; Vecchiato C; Fisogni S; Pusceddu I; Cortelazzo S
    Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
    Kharfan-Dabaja MA; Al Malki MM; Deotare U; Raj RV; El-Jurdi N; Majhail N; Cherry MA; Bashir Q; Darrah J; Nishihori T; Sibai H; Hamadani M; de Lima M; Gerds AT; Selby G; Qazilbash MH; Forman SJ; Ayala E; Lipton JH; Hari PN; Muzzafar T; Zhang L; Olteanu H; Perkins J; Sokol L; Kumar A; Ahmed S
    Br J Haematol; 2017 Dec; 179(5):781-789. PubMed ID: 28980314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.
    Dietrich S; Andrulis M; Hegenbart U; Schmitt T; Bellos F; Martens UM; Meissner J; Krämer A; Ho AD; Dreger P
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1250-4. PubMed ID: 21215813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.
    Jegalian AG; Buxbaum NP; Facchetti F; Raffeld M; Pittaluga S; Wayne AS; Jaffe ES
    Haematologica; 2010 Nov; 95(11):1873-9. PubMed ID: 20663945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission.
    Male HJ; Davis MB; McGuirk JP; Abhyankar S; Aljitawi OS; Zhang D; Ganguly S
    Int J Hematol; 2010 Sep; 92(2):398-400. PubMed ID: 20697854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation.
    Wang SY; Thomassen K; Kurch L; Opitz S; Franke GN; Bach E; Platzbecker U; Kayser S
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e579-e582. PubMed ID: 33795208
    [No Abstract]   [Full Text] [Related]  

  • 16. Case of blastic plasmacytoid dendritic cell neoplasm.
    Aoi J; Ogata A; Makino T; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Ihn H
    J Dermatol; 2012 Dec; 39(12):1066-7. PubMed ID: 22970734
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Kharfan-Dabaja MA; Cherry M
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
    Picardi A; Fabritiis Pd Pd; Cudillo L; Dentamaro T; Cupelli L; Ballatore G; Venditti A; Caravita T; Cristina Cox M; Catalano G; Amadori S
    Hematol J; 2004; 5(1):24-31. PubMed ID: 14745426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.